Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Posdinemab is the second tau-directed investigational therapy by J&J that has received fast track designation from FDA this year for Alzheimer’s disease. The final guidance is a revision of a policy ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...

Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new ...